Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-60,400
Closed -$3.66M 164
2025
Q1
$3.66M Buy
+60,400
New +$4.21M 0.45% 48
2021
Q4
Sell
-98,700
Closed -$6.79M 214
2021
Q3
$6.79M Sell
98,700
-101,300
-51% -$7.7M 0.48% 51
2021
Q2
$16.8M Hold
200,000
1.36% 16
2021
Q1
$16.3M Buy
+200,000
New +$17.1M 0.55% 40
2020
Q4
Sell
-150,000
Closed -$13.5M 245
2020
Q3
$13.5M Hold
150,000
0.97% 25
2020
Q2
$15.6M Buy
+150,000
New +$14.5M 1.24% 20
2020
Q1
Sell
-80,000
Closed -$6.99M 164
2019
Q4
$6.99M Buy
+80,000
New +$6.83M 1.13% 27

Other funds holding INCY

Ikarian Capital's INCY Position: Q4 2021 in Review

Ikarian Capital sold out of Incyte (INCY) in Q4 2021, closing a stake of 32,666 shares — an estimated $2.25M sold.

Ikarian Capital first reported a position in INCY in Q2 2020 and held it in 4 quarters. The position peaked at $3.07M in Q2 2021. 525 funds tracked by Wall St. Rank hold INCY as of Q4 2021.

  • Ikarian Capital reported no remaining Incyte position as of Q4 2021 after selling out during the quarter.
  • Ikarian Capital sold 32,666 Incyte shares in Q4 2021, an estimated $2.25M.
  • Ikarian Capital first reported a position in Incyte in Q2 2020 and held it in 4 quarters.
  • Ikarian Capital's Incyte position peaked at $3.07M in Q2 2021.
  • 525 funds tracked by Wall St. Rank held Incyte as of Q4 2021.

Based on Ikarian Capital's 13F filing for Q4 2021, filed 14 Feb 2022.